Trinity Biotech reported $386.76M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 2.94M Mar/2026
Bayer EUR 982.42M 0 Mar/2026
Bio-Rad Laboratories USD 26.74M 91K Jun/2026
EDAP TMS EUR 37.48M 90K Mar/2026
J&J USD 2.41B 1.35M Mar/2026
Mesa Laboratories USD 349.53M 3.53M Sep/2024
OraSure Technologies USD 70.39M 1.87M Dec/2025
Plus Therapeutics USD 275K 138.4M Mar/2026
Roche Holding CHF 796.77M 1.15M Jun/2026
Siemens EUR 762.74M 0 Jun/2026
Thermo Fisher Scientific USD 371.62M 1000 Jun/2026
Tosoh JPY 307.89M 2K Jun/2026
Trinity Biotech USD 386.76M 1.57M Dec/2025
Veracyte USD 79.79M 1000 Jun/2026